Search
Login
My Portfolios Login
TradeMachine® Login
CML Research Pro Login
PatternFinder Login
Sign Up
Get TradeMachine®
Get CML Research
Get PatternFinder
Get TradeMachine®
Get CML Research
Get PatternFinder
Compare Products
Home
My Portfolios
CMLViz News
Breaking
Stock
Scanner
Tear Sheet
News
Profile
Stats
Stock Chart
Pivot Points
Financial Charts
Holders
Analysts
Day Trader
Back-Tester
SPX
3,955.73
-17.80
(
-0.45%
)
Dow 30
-0.29%
QQQ
-0.94%
VIX
20.95
+0.35
(
+1.70%
)
Pliant Therapeutics Inc
NASDAQ:PLRX 2:41:04 PM EDT
26.28
-0.05
(
-0.19%
)
Products
Pliant Therapeutics Announces FDA Clearance Of Investigational NDA For PLN-101095
Published: 02/02/2023 14:26 GMT
PLRX
Pliant Therapeutics Inc (
PLRX
)
- Pliant Therapeutics Announces FDA Clearance of Investigational New Drug Application for Pln-101095, a Novel Integrin Inhibitor for the Treatment of Solid Tumors.
